` ARE (Alexandria Real Estate Equities Inc) vs S&P 500 Comparison - Alpha Spread

ARE
vs
S&P 500

Over the past 12 months, ARE has underperformed S&P 500, delivering a return of -21% compared to the S&P 500's 24% growth.

Stocks Performance
ARE vs S&P 500

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ARE vs S&P 500

Loading
ARE
S&P 500
Difference

Performance By Year
ARE vs S&P 500

Loading
ARE
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Alexandria Real Estate Equities Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Alexandria Real Estate Equities Inc
Glance View

Economic Moat
None
Market Cap
16.8B USD
Industry
Real Estate

In the bustling hub of urban life sciences and technology campuses, Alexandria Real Estate Equities Inc. has carved a niche that integrates real estate acumen with a deep understanding of the life sciences industry. Born in 1994, it emerged as a visionary undertaking, keenly focused on serving the unique needs of life sciences enterprises by providing strategically located and highly sophisticated laboratory and office spaces. Headquartered in Pasadena, California, Alexandria has built a reputation not just as a landlord, but as a partner to a broad spectrum of innovative tenants ranging from biotech startups to global pharmaceutical giants. The company’s properties are primarily located in top innovation clusters like Greater Boston, San Francisco Bay Area, New York City, and San Diego, ensuring close proximity to leading research institutions and talent pools. Alexandria’s business model thrives on a keen strategy of acquiring, developing, and operating properties in these sought-after corridors, where science and technology entrepreneurship flourishes. The company generates revenue through leasing its carefully curated real estate portfolio, with rental income forming the backbone of its financial success. Each property is designed or upgraded to meet the demanding requirements of its tenants, often including state-of-the-art laboratory facilities and amenities that foster collaboration and innovation. This not only enables Alexandria to command premium lease rates but also helps maintain high occupancy levels. The uniqueness of its properties and strategic presence in dynamic markets provide Alexandria with a strong competitive edge, underpinning its growth and establishing its stature in the specialized domain of life sciences real estate investment trusts (REITs).

ARE Intrinsic Value
111.26 USD
Undervaluation 12%
Intrinsic Value
Price
Back to Top